Ameritas Investment Company’s Elevance Health ELV Stock Holding History

Ameritas Investment Company’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$615K	Buy	1,648 +1,310	+388%	+$498K	0.03%	373
2021 Q2	$648K	Buy	338 +98	+41%	+$37.5K	0.03%	362
2021 Q1	$86.1K	Buy	+240	New	+$77.2K	0.01%	796
2020 Q2	–	Sell	-1,625	Closed	-$343K	–	652
2020 Q1	$343K	Buy	1,625 +8	+0.5%	+$2.18K	0.05%	242
2019 Q4	$488K	Buy	1,617 +1,000	+162%	+$275K	0.1%	190
2019 Q3	$148K	Buy	+617	New	+$169K	0.03%	388
2019 Q2	–	Sell	-1,000	Closed	-$287K	–	398
2019 Q1	$287K	Sell	1,000 -5,447	-84%	-$1.58M	0.05%	253
2018 Q4	$1.69M	Buy	+6,447	New	+$1.77M	0.37%	64

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return

Ameritas Investment Company's ELV Position: Q3 2021 in Review

Ameritas Investment Company increased its Elevance Health (ELV) stake by 388% in Q3 2021, buying an estimated $498K and bringing the position to 1,648 shares worth $615K. The position accounts for 0.03% of the portfolio, ranked #373.

Ameritas Investment Company first reported a position in ELV in Q4 2018 and has held it in 8 quarters since. The position peaked at $1.69M in Q4 2018. 1,215 funds tracked by Wall St. Rank hold ELV as of Q3 2021.

Ameritas Investment Company held 1,648 shares of Elevance Health worth $615K as of Q3 2021.
Ameritas Investment Company bought 1,310 Elevance Health shares in Q3 2021, an estimated $498K.
Elevance Health made up 0.03% of Ameritas Investment Company's portfolio in Q3 2021, its #373 holding.
Ameritas Investment Company first reported a position in Elevance Health in Q4 2018 and has held it in 8 quarters since.
Ameritas Investment Company's Elevance Health position peaked at $1.69M in Q4 2018.
1,215 funds tracked by Wall St. Rank held Elevance Health as of Q3 2021.

Based on Ameritas Investment Company's 13F filing for Q3 2021, filed 12 Nov 2021.